Table 3:

Vestibular endolymphatic hydrops according to Nakashima grading

SE (%) (95% CI)SP (%) (95% CI)PPV (%) (95% CI)NPV (%) (95% CI)
Symptomatic MD vs asymptomatic MD74 (53–88)65 (43–83)71 (51–86)68 (45–85)
Symptomatic MD vs healthy74 (53–88)83 (62–95)83 (62–95)74 (53–88)
Symptomatic MD vs SSHL74 (53–88)58 (37–77)67 (47–82)67 (43–85)
Symptomatic MD vs other74 (53–88)69 (57–79)48 (32–63)88 (75–94)
  • Note:—SE indicates sensitivity; SP, specificity.